Insufficient scRNA-seq data for expression of ALG1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 846.74 | 328 / 328 | 100% | 10.87 | 178 / 178 |
stomach | 100% | 775.14 | 358 / 359 | 100% | 15.99 | 286 / 286 |
skin | 100% | 851.49 | 1807 / 1809 | 100% | 17.73 | 470 / 472 |
intestine | 100% | 680.73 | 966 / 966 | 99% | 17.77 | 524 / 527 |
breast | 100% | 613.89 | 459 / 459 | 99% | 16.44 | 1107 / 1118 |
esophagus | 100% | 515.95 | 1441 / 1445 | 99% | 10.03 | 181 / 183 |
prostate | 100% | 591.48 | 245 / 245 | 99% | 13.78 | 495 / 502 |
ovary | 100% | 528.37 | 180 / 180 | 99% | 10.15 | 424 / 430 |
thymus | 100% | 730.92 | 653 / 653 | 98% | 11.23 | 595 / 605 |
kidney | 100% | 555.88 | 89 / 89 | 98% | 11.45 | 885 / 901 |
uterus | 100% | 616.30 | 170 / 170 | 97% | 10.47 | 447 / 459 |
lung | 98% | 566.59 | 564 / 578 | 100% | 11.92 | 1152 / 1155 |
liver | 100% | 597.97 | 226 / 226 | 97% | 10.35 | 395 / 406 |
bladder | 100% | 610.48 | 21 / 21 | 97% | 12.04 | 490 / 504 |
brain | 98% | 415.30 | 2598 / 2642 | 99% | 9.00 | 695 / 705 |
adrenal gland | 100% | 1169.93 | 258 / 258 | 93% | 9.98 | 213 / 230 |
adipose | 100% | 603.40 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 18.16 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 11.01 | 29 / 29 |
spleen | 100% | 827.87 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 10.21 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.85 | 1 / 1 |
blood vessel | 100% | 460.43 | 1330 / 1335 | 0% | 0 | 0 / 0 |
muscle | 96% | 263.53 | 770 / 803 | 0% | 0 | 0 / 0 |
heart | 95% | 304.24 | 815 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 89% | 430.08 | 831 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006486 | Biological process | protein glycosylation |
GO_0006487 | Biological process | protein N-linked glycosylation |
GO_0006488 | Biological process | dolichol-linked oligosaccharide biosynthetic process |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0098554 | Cellular component | cytoplasmic side of endoplasmic reticulum membrane |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0004578 | Molecular function | chitobiosyldiphosphodolichol beta-mannosyltransferase activity |
GO_0000030 | Molecular function | mannosyltransferase activity |
Gene name | ALG1 |
Protein name | ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase Chitobiosyldiphosphodolichol beta-mannosyltransferase (EC 2.4.1.142) (Asparagine-linked glycosylation protein 1 homolog) (Beta-1,4-mannosyltransferase) (GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase) (GDP-mannose-dolichol diphosphochitobiose mannosyltransferase) (Mannosyltransferase-1) (MT-1) (hMat-1) |
Synonyms | UNQ861/PRO1870 HMT1 HMAT1 PSEC0061 |
Description | FUNCTION: Catalyzes the addition of the first of nine mannose moieties to form a dolichol-lipid linked oligosaccharide intermediate required for proper N-linked glycosylation. . |
Accessions | A0A804HHW1 ENST00000591783.5 A0A804HKU4 A0A804HJQ1 ENST00000684190.1 ENST00000650085.1 ENST00000682327.1 A0A804HJL6 K7EPU3 ENST00000591822.5 Q9BT22 ENST00000683433.1 ENST00000684008.1 ENST00000586840.1 A0A804HLB7 ENST00000262374.10 [Q9BT22-1] A0A804HKX7 K7EID2 A0A804HJE3 A0A804HKK4 ENST00000682797.1 ENST00000544428.1 [Q9BT22-2] ENST00000588623.5 [Q9BT22-2] ENST00000683710.1 ENST00000682020.1 ENST00000683739.1 [Q9BT22-2] ENST00000682985.1 A0A804HKJ4 A0A804HIG6 ENST00000682206.1 K7EQK1 ENST00000684335.1 |